Gaia Griguolo: ShortHER 10-year survival data and TILs
Gaia Griguolo, Junior Faculty Fixed-term Researcher at University of Padua, posted on X about recent paper by Maria Vittoria Dieci et al., titled “Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer” published on JAMA Oncology.
Authors: Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Alessio Schirone, Luigi Cavanna, Antonino Musolino, Francesco Giotta, Anita Rimanti, Ornella Garrone, Elena Bertone, Katia Cagossi, Samanta Sarti, Antonella Ferro, Federico Piacentini, Enrico Orvieto, Melinda Sanders, Federica Miglietta, Davide Massa, Sara Balduzzi, Pierfranco Conte, Roberto D’Amico, Valentina Guarneri
“ShortHER 10-year survival data and TILs!
First study showing prognostic role of TILs on OS in HER2+ early BC.
Patients with TILs≥20% did not show any additional risk with shorter trastuzumab duration.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023